JP4712966B2 - 単純ヘルペスウイルス侵入メディエーターのためのリガンドおよびその使用方法 - Google Patents
単純ヘルペスウイルス侵入メディエーターのためのリガンドおよびその使用方法 Download PDFInfo
- Publication number
- JP4712966B2 JP4712966B2 JP2000502082A JP2000502082A JP4712966B2 JP 4712966 B2 JP4712966 B2 JP 4712966B2 JP 2000502082 A JP2000502082 A JP 2000502082A JP 2000502082 A JP2000502082 A JP 2000502082A JP 4712966 B2 JP4712966 B2 JP 4712966B2
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- hvem
- cells
- ltβr
- pma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
- C07K14/5255—Lymphotoxin [LT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5196497P | 1997-07-07 | 1997-07-07 | |
| US08/898,234 | 1997-07-30 | ||
| US60/051,964 | 1997-07-30 | ||
| US08/898,234 US6140467A (en) | 1997-07-07 | 1997-07-30 | Ligand for herpes simplex virus entry mediator and methods of use |
| PCT/US1998/013897 WO1999002563A1 (en) | 1997-07-07 | 1998-07-07 | Ligand for herpes simplex virus entry mediator and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001509373A JP2001509373A (ja) | 2001-07-24 |
| JP2001509373A5 JP2001509373A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
| JP4712966B2 true JP4712966B2 (ja) | 2011-06-29 |
Family
ID=26730006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000502082A Expired - Fee Related JP4712966B2 (ja) | 1997-07-07 | 1998-07-07 | 単純ヘルペスウイルス侵入メディエーターのためのリガンドおよびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6140467A (cg-RX-API-DMAC7.html) |
| EP (1) | EP1003782B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4712966B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100620334B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN1891714B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE495240T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU741419B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2296737C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69842096D1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI222453B (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999002563A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6635743B1 (en) | 1996-03-22 | 2003-10-21 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II and methods of use |
| US6479254B2 (en) | 1996-03-22 | 2002-11-12 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II |
| US6495520B2 (en) | 1996-03-22 | 2002-12-17 | Human Genome Sciences, Inc. | Apoptosis Inducing Molecule II and methods of use |
| US7964190B2 (en) | 1996-03-22 | 2011-06-21 | Human Genome Sciences, Inc. | Methods and compositions for decreasing T-cell activity |
| US6998108B1 (en) | 1997-07-07 | 2006-02-14 | La Jolla Institute For Allergy And Immunology | Antibodies to p30 polypeptides and methods making and using same |
| US7118742B2 (en) * | 1997-07-07 | 2006-10-10 | La Jolla Institute For Allergy And Immunology | Ligand for herpes simplex virus entry mediator and methods of use |
| WO2000010591A1 (en) * | 1998-08-18 | 2000-03-02 | The Trustees Of The University Of Pennsylvania | Peptides for inhibition of herpes simplex virus entry |
| WO2001079496A2 (en) * | 2000-03-13 | 2001-10-25 | La Jolla Institute For Allergy And Immunology | Ligand for herpes simplex virus entry mediator and methods of use |
| AU2007201279B2 (en) * | 2000-03-13 | 2011-05-26 | La Jolla Institute For Allergy And Immunology | Ligand for herpes simplex virus entry mediator and methods of use |
| ATE365214T1 (de) | 2000-04-12 | 2007-07-15 | Jolla Inst Allergy Immunolog | Ligand des zelleintritt-vermittelnden proteins von herpes simplex und methoden zu dessen verwendungen |
| WO2002032463A1 (en) * | 2000-10-18 | 2002-04-25 | Smithkline Beecham Corporation | Methods of treating cancers by stimulating dendritic cells or lymphomas with certain tnf molecules |
| US7514407B2 (en) * | 2002-03-04 | 2009-04-07 | Nymox Corporation | Spheron component peptides and pharmaceutical compositions |
| US7811983B2 (en) * | 2003-06-11 | 2010-10-12 | The University Of Chicago | Increased T-cell tumor infiltration and eradication of metastases by mutant light |
| ATE382372T1 (de) * | 2003-06-11 | 2008-01-15 | Univ Chicago | Erhöhte t-zell tumor-eindringung durch light- mutanten |
| EP2484696B1 (en) | 2006-08-28 | 2017-08-16 | Kyowa Hakko Kirin Co., Ltd. | Antagonistic hLIGHT-specific human monoclonal antibodies |
| WO2008098183A2 (en) * | 2007-02-08 | 2008-08-14 | The University Of Chicago | Combination therapy for treating cancer |
| JP2012507299A (ja) * | 2008-10-31 | 2012-03-29 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | Light標的分子およびその使用 |
| GB201701194D0 (en) | 2017-01-24 | 2017-03-08 | Capella Bioscience Ltd | Antigen binding molecules that bind light |
| CN107213456B (zh) * | 2017-05-25 | 2020-08-21 | 苏州华测生物技术有限公司 | 淋巴毒素衍生物的新用途 |
| US11312781B2 (en) | 2018-01-24 | 2022-04-26 | Capella Bioscience Ltd. | Antigen binding molecules that bind LIGHT |
| WO2019238966A1 (en) * | 2018-06-15 | 2019-12-19 | Universität Bern | LIGANDS TO LIGHT OR ITS RECEPTOR LTßR FOR USE IN HAEMATOLOGIC MALIGNANCIES |
| CA3173873A1 (en) | 2020-04-01 | 2021-10-07 | Avalo Therapeutics, Inc. | Methods and treatment involving excess free light |
| CN112511569B (zh) * | 2021-02-07 | 2021-05-11 | 杭州筋斗腾云科技有限公司 | 网络资源访问请求的处理方法、系统及计算机设备 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ298711B6 (cs) * | 1995-01-26 | 2008-01-02 | Biogen Idec Ma Inc. | Farmaceutické prostredky aktivující LT-beta receptor pro lécení nebo omezení pokracování, závažnosti nebo úcinku neoplazie, zpusob selekce LT-beta receptor aktivujícího cinidla a protilátky proti LT-beta receptoru |
| AU2363695A (en) * | 1995-04-27 | 1996-11-18 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptors |
| US5654174A (en) * | 1995-07-07 | 1997-08-05 | Competitive Technologies, Inc. | Herpes simplex virus glycoprotein D variants |
| US6291207B1 (en) * | 1995-07-28 | 2001-09-18 | Northwestern University | Herpes virus entry receptor protein |
| EP0904278A4 (en) * | 1996-03-22 | 1999-09-15 | Human Genome Sciences Inc | MOLECULE II INDUCER OF APOPTOSIS |
| US6479254B2 (en) * | 1996-03-22 | 2002-11-12 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II |
| WO1998003648A1 (en) * | 1996-07-19 | 1998-01-29 | Takeda Chemical Industries, Ltd. | Fas ligand-like protein, its production and use |
| JP4090092B2 (ja) * | 1996-07-19 | 2008-05-28 | 武田薬品工業株式会社 | 新規Fasリガンド様タンパク質およびそのDNA |
| BR9712670A (pt) * | 1996-10-25 | 1999-10-19 | Biogen Inc | Receptores para linfotoxina-beta, anticorpos anti-receptor para linfotoxina, e anticorpos antiligante de linfotoxina como agentes terapêuticos para o tratamento de doencas imunológicas |
| WO1998018824A1 (en) * | 1996-10-30 | 1998-05-07 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor-like 2 |
| JP2001524985A (ja) * | 1997-05-12 | 2001-12-04 | スミスクライン・ビーチャム・コーポレイション | ヒト腫瘍壊死因子受容体様2(tr2)抗体 |
| US6346388B1 (en) * | 1997-08-13 | 2002-02-12 | Smithkline Beecham Corporation | Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| US6051385A (en) * | 1997-10-22 | 2000-04-18 | The Regents Of The University Of Michigan | Compositions and methods for identifying and testing therapeutics against HSV infection |
| AU2972199A (en) * | 1998-02-20 | 1999-09-06 | Reinhard Ebner | Apoptosis inducing molecule ii and methods of use |
-
1997
- 1997-07-30 US US08/898,234 patent/US6140467A/en not_active Expired - Lifetime
-
1998
- 1998-07-07 TW TW087110978A patent/TWI222453B/zh not_active IP Right Cessation
- 1998-07-07 AT AT98933153T patent/ATE495240T1/de not_active IP Right Cessation
- 1998-07-07 AU AU82882/98A patent/AU741419B2/en not_active Ceased
- 1998-07-07 JP JP2000502082A patent/JP4712966B2/ja not_active Expired - Fee Related
- 1998-07-07 CA CA2296737A patent/CA2296737C/en not_active Expired - Fee Related
- 1998-07-07 EP EP98933153A patent/EP1003782B1/en not_active Expired - Lifetime
- 1998-07-07 DE DE69842096T patent/DE69842096D1/de not_active Expired - Lifetime
- 1998-07-07 CN CN2006100737047A patent/CN1891714B/zh not_active Expired - Fee Related
- 1998-07-07 WO PCT/US1998/013897 patent/WO1999002563A1/en not_active Ceased
- 1998-07-07 KR KR1020007000137A patent/KR100620334B1/ko not_active Expired - Fee Related
- 1998-07-07 CN CN98808663A patent/CN1268953A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2296737C (en) | 2012-07-03 |
| US6140467A (en) | 2000-10-31 |
| ATE495240T1 (de) | 2011-01-15 |
| EP1003782B1 (en) | 2011-01-12 |
| CN1268953A (zh) | 2000-10-04 |
| CN1891714B (zh) | 2011-06-22 |
| AU8288298A (en) | 1999-02-08 |
| HK1026913A1 (en) | 2000-12-29 |
| EP1003782A1 (en) | 2000-05-31 |
| EP1003782A4 (en) | 2002-07-10 |
| AU741419B2 (en) | 2001-11-29 |
| WO1999002563A1 (en) | 1999-01-21 |
| KR20010021579A (ko) | 2001-03-15 |
| TWI222453B (en) | 2004-10-21 |
| DE69842096D1 (de) | 2011-02-24 |
| CA2296737A1 (en) | 1999-01-21 |
| KR100620334B1 (ko) | 2006-09-13 |
| CN1891714A (zh) | 2007-01-10 |
| JP2001509373A (ja) | 2001-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6140467A (en) | Ligand for herpes simplex virus entry mediator and methods of use | |
| US6362325B1 (en) | Murine 4-1BB gene | |
| EP1887014B1 (en) | Human toll homologues | |
| US20110171242A1 (en) | Ligand for herpes simplex virus entry mediator and methods of use | |
| CA2292835A1 (en) | Ntn-2 member of tnf ligand family | |
| JP2000060580A (ja) | Tnfの相同体tl5 | |
| US20030219860A1 (en) | TRAIN-R: a cysteine rich member of the TNF-receptor family | |
| CZ2000490A3 (cs) | Interleukin-18-vazebné proteiny, příprava a použití | |
| AU7713098A (en) | Ntn-2 member of tnf ligand family | |
| JPH10327878A (ja) | 腫瘍壊死因子関連のレセプター、tr6 | |
| JP2003024085A (ja) | 腫瘍壊死関連受容体tr7 | |
| WO2001079496A2 (en) | Ligand for herpes simplex virus entry mediator and methods of use | |
| WO1999026977A1 (en) | Novel receptors opg-2 | |
| JPH1118786A (ja) | 腫瘍壊死関連受容体tr7 | |
| US6998108B1 (en) | Antibodies to p30 polypeptides and methods making and using same | |
| EP1274840B1 (en) | Ligand for herpes simplex virus entry mediator and methods of use | |
| HK1026913B (en) | Ligand for herpes simplex virus entry mediator and methods of use | |
| AU2007201279B2 (en) | Ligand for herpes simplex virus entry mediator and methods of use | |
| WO2002074803A2 (en) | Regulation of human icos v protein | |
| AU2001253387A2 (en) | Ligand for herpes simplex virus entry mediator and methods of use | |
| CA2274803C (en) | Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050620 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050620 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080805 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081029 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081106 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090205 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090303 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090522 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090529 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090903 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100810 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101210 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110125 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110301 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110324 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |